top of page

RIS3 strategies and Policy documents 

RIS3 2021-2027 Strategies

SHAPIRE ICONS DOCS NEW 3-2.png

Germany

Romania

Netherlands

Malta

Brittany

Kainuu

Lisboa

 

Brussels

 

Lombardia

Regione Basilicata

Regione Sardegna

 

Regiunea Sud Muntenia

 

Emilia Romagna

 

 

Regional and National updated RIS3 2021-2027

SAPHIRe analysed 67 updated regional RIS3 2021-2027 and 5 updated national RIS3 2021-2027.

 

For the regional updated RIS3 2021-2027, the results are

  • 70% with PM priority (47/67)

  • 21% with health priority (14/67)

  • 9% with no health related priority (6/67)

 

For the national updated RIS3 2021-2027, the results are

  • 60% with PM priority (3/5)

  • 41% with health priority (2/5)

 

Remarks :

  • PM is taken more than literally “Personalised Medicine”, in the broad sense = Precision Medicine, Stratified Medicine, Tailor-made Medicine, Targeted Medicine, Individualised Medicine, NanoMedicine, Advanced Diagnostics…

  • The map is based on NUTS2- level (basic regions for the application of regional policies) but some regional updated RIS3 2021-2027 are on NUTS3 -level (like krajs in CZ, and counties in SE); for NUTS levels (Nomenclature of Territorial Units for Statistics, hierarchical classification of European regions) see https://ec.europa.eu/eurostat/web/nuts/background

       Some regions are still in updating process of their RIS3; for RIS3       see https://s3platform.jrc.ec.europa.eu/design

Regional & national updated RIS3 2021-2027 map

Regional and National updated RIS3 2021-2027.png
bottom of page